Big news! 📰 We’re partnering with @ElegenBio, the leader in next-generation DNA manufacturing, to increase access to high-complexity clonal genes from 5 kb to 15 kb. Powered by Elegen’s patented cell-free linear DNA synthesis technology, ENFINIA™ Plasmid DNA are NGS-verified and shipped from the U.S. Read more here: https://t.co/cyTzgUVbTZ
#DNAmanufacturing #genomicspartnership #oligos #genomicsnews #lifesciencesnews
Now you can design custom gene panels with our partners at @TwistBioscience & sequence them with long and accurate HiFi reads to resolve complex gene families like HLA or cytochrome P450 genes with haplotype resolution. #ESHG2022
Delighted to share that we at Twist Bioscience continue to expand both our applications menu and our partnership with a world class leader in NGS with the commercial launch of the new Twist canine exome workflow. Canine as a model organism for human onco…https://t.co/atG1MB0X6x
Our Director of R&D Mara Couto-Rodriguez and @TwistBioscience's Rebecca Nugent will be presenting next week at the @LabRoots 2021 Genetics Virtual Week! Their talks will be available on-demand starting at 12 pm on April 21.
See more on the event here: https://t.co/sxmB1vK92x
Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights https://t.co/nnd9BFXISx with @TwistBioscience and @BiotiaNYC (COI, co-founder)!
It's not too late to register for the COVID-19: Detection Technologies and Neurological Impact Virtual Event held by @harvardbrainsci next Wednesday (1/27) from 5-7pm ET!
This can't-miss event includes Biotia co-founders
@Niamh_Oh and @mason_lab
https://t.co/F7rEq9er3V
FACT CHECK: Our elections are over when all the votes are counted.
But if your lawyers want to try us, we’d be happy to defeat you in court one more time.
#SARSCoV2#RNA can be detected from NP samples via a direct RT-qPCR assay that omits the RNA extraction step! Happy to see our Synthetic #SARSCoV2 Controls used!
#COVID19@poisondartfrog7@jwocro @DrDebraLeonard
DIRECT RT-qPCR DETECTION OF...| bioRxiv https://t.co/8k4u7jjy7Q
In a matter of days, the @BroadGenomics Platform converted its clinical processing lab to a #COVID19 testing facility capable of testing 2,000 samples a day.
Read how the platform worked to modify protocols, train staff members, and reshape lab spaces:
https://t.co/Ad9LVuxV7d
The Broad Institute Clinical Research Sequencing Platform, in partnership with @MassGov, @MassDPH, and area hospitals, has begun processing #COVID19 patient test samples. The CLIA-certified lab now has capacity to process ~2,000 tests per day. #coronavirus https://t.co/1CAc6Nda9P
Happy to help with anyone needing SARS-CoV-2 controls for their critical work - please reach out ASAP and we can customize quickly as needed. https://t.co/TiByjFFwRc